Pharmaceutical Technology-10-02-2015

Pharmaceutical Technology

Identifying Powder Properties that Define Process Performance

October 02, 2015

Troubleshooting

38

10

Multi-faceted powder characterization, including measurement of dynamic properties, can be used to correlate powder properties and process performance to support equipment selection, optimization, and troubleshooting.

Parenteral Packaging Advances

October 02, 2015

Packaging Forum

38

10

Manufacturers of parenteral drugs face challenges to increase efficiency, control particulates, control extractables and leachables, and eliminate product/package interactions; new containers and packaging equipment offer increased options.

Serialization Shake Out

October 02, 2015

Regulatory Watch

38

10

The complexity of new packaging regulations laid out in the Falsified Medicines Directive could threaten the existence of smaller pharma and packaging companies.

Investigating Biologics

October 02, 2015

Ask the Expert

38

10

Susan Schniepp, distinguished fellow, and Andrew Harrison, chief regulatory affairs officer and general counsel, both of Regulatory Compliance Associates, discuss performing investigations of biological products.

Control Systems

October 02, 2015

Product Spotlight

38

10

Ross SysCon’s UL-rated and CE-marked control systems are custom-designed for industrial processes such as mixing, pumping, chemical dosing, dilution, heat exchange, separation, drying, and waste treatment.

Stretching Product Value through Reformulation Strategies

October 02, 2015

Cover Story

38

10

New formulations that enhance bioavailability, optimize drug-delivery profiles, reduce dosing frequency, or improve patient experience have the potential to deliver quicker returns on investments than developing a completely new drug.

Pharmaceutical Technology, October 2015 Issue (PDF)

October 02, 2015

Issue PDF

38

10

Click the title above to open the Pharmaceutical Technology October 2015 issue in an interactive PDF format.

FDA Faces Controversy Over Quality Metrics and Biosimilars

September 15, 2015

Regulatory Watch

38

10

Manufacturers challenge details in new policies designed to promote access to important therapies.